Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma
David J Pinato,
Tadaaki Arizumi,
Jeong Won Jang,
Elias Allara,
Puvan I Suppiah,
Carlo Smirne,
Paul Tait,
Madhava Pai,
Glenda Grossi,
Young Woon Kim,
Mario Pirisi,
Masatoshi Kudo,
Rohini Sharma
Aug 14, 2017
BACKGROUND: The prognosis of patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE) is variable, despite a myriad of prognostic markers. We compared and integrated the established...